Aravind假性剥脱研究:无晶状体震颤及瞳孔非缩小眼的术后一年手术结果
PXF组与对照组术中并发症率分别为2.9%和1.9%(P=0.29),术后1年并发症率分别为2.7%和2.5%(P=0.82),1年最佳矫正视力相当(P=0.09)。结论提示无临床明显悬韧带病变的PXF眼白内障手术风险未显著增加。
要点
- 无晶状体震颤、前房不浅、瞳孔≥4mm的PXF眼术中并发症率2.9%,与对照1.9%无显著差异(P=0.29)。
- 术后1年PXF组与对照组并发症率分别为2.7%和2.5%(P=0.82),最佳矫正视力相当(P=0.09)。
- PXF组平均内皮细胞丢失14.7%,对照组12.7%,校正年龄和核混浊后P=0.066。
核心结论
- 无临床明显术前悬韧带病变的PXF眼,尽管瞳孔较小且白内障更致密,白内障术后术中及术后并发症风险未显著高于对照组,视力结局相当。
研究设计与样本
- PXF组和对照组分别随机接受单件式丙烯酸IOL(SA60AT)或三件式丙烯酸IOL(MA60AS),PXF组另随机接受或不接受囊袋张力环。
- 所有眼行超声乳化联合IOL植入,术后1天、1个月、3个月和1年随访。
主要发现
- PXF组平均年龄63.0±6.9岁,对照组57.9±7.3岁(P<0.001);PXF组男性更多(P=0.014)、核混浊分级>4级更多(P=0.001)、瞳孔<6mm更多(P<0.001)。
- 术中并发症率PXF组2.9%,对照组1.9%(P=0.29)。
- 术后1年并发症率PXF组2.7%,对照组2.5%(P=0.82);1年最佳矫正视力相当(P=0.09)。
- 1年平均内皮细胞丢失PXF组14.7%,对照组12.7%,校正年龄和核混浊后P=0.066。
临床怎么用
- 对于无晶状体震颤、前房不浅且瞳孔≥4mm的PXF眼,可按常规白内障手术管理,无需过度担忧并发症风险。
- 术中仍应注意PXF眼瞳孔较小、核混浊较重等特点,个体化选择IOL类型及是否使用囊袋张力环。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare intraoperative complication rates, 1-year visual outcomes, and postoperative complication rates over the first postoperative year in eyes with and without pseudoexfoliation undergoing cataract surgery. DESIGN: Prospective, comparative, interventional study. PARTICIPANTS: Nine hundred thirty eyes with cataract and uncomplicated pseudoexfoliation (without phacodonesis, clinically shallow anterior chambers, or pupil size <4 mm) and 476 controls with cataract but without pseudoexfoliation recruited from 4 centers of the Aravind Eye Care System in Southern India. The 2 groups were randomized separately to receive either a single-piece acrylic intraocular lens (IOL; SA60AT; Alcon Laboratories, Fort Worth, TX) or a 3-piece acrylic IOL (MA60AS; Alcon Laboratories). The pseudoexfoliation group also was randomized to receive or not receive a capsular tension ring. METHODS: All eyes underwent phacoemulsification with IOL implantation and were followed up at 1 day, 1 month, 3 months, and 1 year after surgery. MAIN OUTCOME MEASURES: Association of pseudoexfoliation status with intraoperative complication rates, 1-year best-corrected visual acuity, and any other complications. RESULTS: Mean ages were 63.0±6.9 years and 57.9±7.3 years in the pseudoexfoliation and control groups, respectively (P < 0.001). Pseudoexfoliation patients were more likely to be men (P = 0.014), to have a nuclear opalescence grade of more than 4 (P = 0.001), and to have a pupil size of less than 6 mm (P < 0.001) when compared with controls. Intraoperative complication rates were 2.9% and 1.9% in the pseudoexfoliation and control groups, respectively (P = 0.29). One-year postoperative best-corrected visual acuity was comparable (P = 0.09). Complication rates at 1 year were 2.7% and 2.5% in the pseudoexfoliation and control groups, respectively (P = 0.82). Average endothelial cell loss was 14.7% in the pseudoexfoliation group and 12.7% in the control group at 1 year (P = 0.066) when adjusting for age and nuclear opacity. CONCLUSIONS: Pseudoexfoliation eyes without shallow anterior chamber, small pupils, or apparent zonulopathy may represent eyes with lower risks of complications. Despite smaller pupils and denser cataracts, pseudoexfoliation eyes without clinically apparent preoperative zonulopathy were not at a higher risk of intraoperative or postoperative complications or worse visual outcomes after cataract surgery.
引用
- Haripriya A, Ramulu PY, Chandrashekharan S, et al. The Aravind Pseudoexfoliation Study: Surgical and First-Year Postoperative Results in Eyes without Phacodonesis and Nonmiotic Pupils. Ophthalmology. 2018. PMID: 30339878. doi:10.1016/j.ophtha.2018.10.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。